Original contribution
Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver

https://doi.org/10.1016/j.mri.2012.01.002Get rights and content

Abstract

Purpose

The purpose of this study was to determine whether or not adding diffusion-weighted magnetic resonance imaging (DWI) to conventional magnetic resonance (MR) imaging sequences improves the characterization of small hepatocellular carcinoma (HCC) (≤2 cm) in the setting of cirrhotic liver compared to conventional sequences alone.

Materials and Methods

A total of 62 cirrhotic liver patients with 82 nodules smaller than 2 cm in diameter were enrolled, and all lesions were pathologically confirmed. For the first reading session, which included precontrast T1- and T2-weighted images and T1 dynamic contrast-enhanced images, preindicated lesions by a study coordinator were characterized by two radiologists. They determined the confidence levels in consensus for the presence of small HCC into four grades. In another session, respiratory-triggered diffusion-weighted MR images (b factor=50, 400 and 800 s/mm2) were added to the previously reviewed images, and the same two radiologists again determined the confidence levels. The diagnostic performance of the combined DWI–conventional sequences set and the conventional sequences alone set was evaluated using receiver operating characteristic curves. Sensitivity and specificity values for characterizing small HCCs were also calculated.

Results

The area under the receiver operating characteristic curve for the second interpretation session (0.86) was significantly higher (P=.038) than that of the first session (0.76). The sensitivity was significantly increased from 75.7% to 87.8% by adding DWI to the conventional sequences (P=.015). No significant differences were observed for specificity values.

Conclusion

Adding DWI to conventional imaging modalities improves the diagnosis of small HCCs in the cirrhotic liver in terms of diagnostic performance and sensitivity by increasing reader confidence.

Introduction

Early diagnosis of hepatocellular carcinoma (HCC) is of the utmost importance because it allows the detection of candidates for curative treatments such as transplantation, resection or local ablation therapy [1], [2]. With recent advances in radiologic techniques and the systematic surveillance of cirrhotic patients, there has been an increase in the detection of small focal nodular lesions. But HCC is a long multistage process, with variable features at the early stages of this tumor, and a definitive diagnosis of a nodular lesion in liver cirrhosis remains a difficult task. Enhancement in the arterial phase and washout in the portal venous and delayed phases are now regarded as distinctive features of HCC in liver cirrhosis [3]. According to the recently revised and updated American Association for the Study of Liver Diseases (AASLD) criteria, for lesions ≥1 cm, a single dynamic imaging study [multiphasic computed tomographic scan or dynamic magnetic resonance imaging (MRI)] showing this typical vascular pattern is enough to confirm the diagnosis of HCC, whereas for nodules <1 cm, an ultrasound follow-up at 3-month intervals is recommended to detect changes in size or a change in the vascular pattern [4]. But some small HCCs, ≤2 cm, can be misdiagnosed and do not satisfy these imaging criteria in up to 45% of cases using dynamic MRI [5] because of significant overlaps between the dynamic imaging findings of benign and malignant lesions in liver cirrhosis. Intense arterial uptake without washout might be present in regenerative nodules, dysplastic nodules (DNs), focal nodular hyperplasia or arterioportal shunts, and up to 57% of small hypervascular HCCs do not show washout on delayed venous phase [6], [7]. Furthermore, a number of truly hypovascular HCCs do exist [8], [9] and represent 17% of HCCs with a diameter of 1 to 2 cm [10]. Alternative approaches, particularly functional MRI such as diffusion-weighted MRI (DWI), are expected to improve the ability to characterize these small lesions. DWI enables the noninvasive characterization of biological tissues based on the diffusion properties of water molecules, and it has become a practical tool for MRI of the liver [11]. Because DWI is fundamentally different from the conventional morphological and hemodynamic-based imaging techniques, DWI may provide additional information on disease-associated histological changes in lesions. In tumorous structures, cell density considerably increases with a decrease in the extracellular space. This is accompanied by a subsequent decrease in mobility, which leads to restricted diffusion [12]. Meanwhile, DWI has been applied to body MRI, including liver imaging for the assessment of focal lesions according to the restricted water diffusion and the low apparent diffusion coefficient (ADC) values for malignant lesions [13], [14], [15], [16]. To the best of our knowledge, only a limited number of studies have been performed on the use of DWI for the specific detection or characterization of HCC in liver cirrhosis [17], [18], [19], [20], and only one study focused on HCCs smaller than 2 cm [17].

The aim of this prospective study was to investigate additional diagnostic contributions of DWI compared to conventional sequences alone for the characterization of small HCCs (≤20 mm) on the cirrhotic liver using qualitative scoring.

Section snippets

Study population

This study was conducted in agreement with French law (4 March 2002) and the Declaration of Helsinki [21]. The ethics committee at our institute deemed that ethical approval for this study was not required.

Between November 2008 and August 2010, all consecutive cirrhotic patients who underwent MRI of the liver including DWI sequences for characterization of undetermined lesions 2 cm or smaller previously detected during surveillance were eligible for enrolment in this study. Patients were

Characteristics of the lesions

Final diagnoses of the 82 nodules stratified by size are summarized in Table 2. The mean size of the nodules was 14.4±3.8 mm (range, 8–20 mm).

A total of 66 lesions from 53 patients were verified as HCCs. The histopathological grade was available for 65 HCCs. Another 16 lesions in 14 patients were non-HCC lesions (including five patients who also had HCC at the same time). With regard to the number of eligible lesions smaller than 2 cm per patient, 50 patients had one lesion, 6 patients had two

Discussion

The results of our study demonstrated that, in addition to conventional MRI sequences, visual evaluation of DWI sequences yielded a significantly higher diagnostic performance and sensitivity for the diagnosis of small HCCs in patients with liver cirrhosis, especially for well-differentiated HCCs. According to the increased confidence level for the sustained hyperintensity with increasing b factors for most of the small HCCs in our study, the DWI sequences compensated dynamic contrast-enhanced

Acknowledgements

We acknowledge Melisa Bakir, radiology technician, GIE IRM Lyon Nord 103 Grande rue de la Croix-Rousse 69004 Lyon, for technical support.

References (38)

  • M. Kudo

    Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions

    Semin Liver Dis

    (1999)
  • M. Hayashi et al.

    Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material

    Radiology

    (2002)
  • L. Bolondi et al.

    Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

    Hepatology

    (2005)
  • B. Taouli et al.

    Diffusion-weighted MR imaging of the liver

    Radiology

    (2010)
  • D. Koh et al.

    Diffusion-weighted MRI in the body: applications and challenges in oncology

    AJR Am J Roentgenol

    (2007)
  • T. Parikh et al.

    Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging

    Radiology

    (2008)
  • B. Taouli et al.

    Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients

    Radiology

    (2003)
  • M. Bruegel et al.

    Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique

    Eur Radiol

    (2008)
  • F.H. Miller et al.

    Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions

    J Magn Reson Imaging

    (2010)
  • Cited by (61)

    • Imaging in Hepatocellular Carcinoma: What's New?

      2023, Seminars in Ultrasound, CT and MRI
    • ACR Appropriateness Criteria<sup>®</sup> Chronic Liver Disease

      2017, Journal of the American College of Radiology
      Citation Excerpt :

      DWI in MRI can be used for problem solving or increasing confidence when other MR sequences are equivocal. Increased conspicuity of lesions on DWI increases sensitivity and justifies its routine use in MRI in detection of HCC [125,128-130]. Although extracellular gadolinium agents are most commonly used in liver MRI to diagnose HCC, hepatobiliary contrast agents such as gadoxetate disodium (also called gadoxetic acid, Gd-EOB-DTPA) and gadobenate dimeglumine (also called Gd-BOPTA) have also been used in recent years.

    • ACR Appropriateness Criteria<sup>®</sup> Chronic Liver Disease

      2017, Journal of the American College of Radiology
    • Diagnostic approach to focal liver lesions at cross-sectional imaging: a primer for beginners

      2023, European Review for Medical and Pharmacological Sciences
    View all citing articles on Scopus
    View full text